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Leptin is a hormone released from adipose tissue. While this hormone normally acts to
reduce feeding behavior and increase energy expenditure, in obesity, resistance to these
effects occurs even though the hormone is released in large amounts. Although leptin no
longer works to suppress feeding in the obese, leptin retains its potent effects on other
autonomic functions such as blood pressure regulation. Leptin has been associated with
hypertension and increased sympathetic autonomic activity. Therefore, leptin is emerging
as a major contributor to the hypertensive state observed in obesity. Sympathetic control
of blood pressure is maintained principally by autonomic reflex control circuits in the
caudal brainstem. The rostral ventral-lateral medulla (RVLM) is the primary regulator of
the sympathetic nervous system, sending excitatory fibers to sympathetic preganglionic
neurons to regulate sympathetic control over resistance vessels and blood pressure.
Previous studies from our laboratory have shown that neurons in the ventral lateral medulla
express leptin receptors (ObRb). Our present study using pseudo-rabies multi-synaptic
retrograde tract tracing and immunohistochemical methods revealed that neurons within
the RVLM that send sympathetic projections to the kidney express leptin receptors. Acute
microinjection of leptin (1 and 3µg; 40 nL) into the RVLM evoked a significant increase in
Mean Arterial Pressure (MAP) and renal sympathetic nerve activity (RSNA). When the 3µg
dose of leptin was preceded with a leptin antagonist, (SLAN-4; 1 ng), it attenuated the
cardiovascular response of leptin. Taken together, these data suggest that leptin’s actions
within the RVLM may influence blood pressure and renal sympathetic nerve activity.
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INTRODUCTION
Leptin is an adipocyte-derived hormone which signals the avail-
ability of peripheral energy stores. Circulating leptin levels act
as a long term signal of the amount of fat stored in white adi-
pose tissue, while short term fluctuations in leptin levels convey
information regarding acute changes in caloric intake. This infor-
mation is integrated centrally by the autonomic nervous system
to regulate a variety of homeostatic functions, most notably food
intake and energy expenditure (Morris and Rui, 2009;Myers et al.,
2009; Galic et al., 2010; Kelesidis et al., 2010). One mechanism by
which leptin affects energy expenditure is by increasing sympa-
thetic tone (Eikelis et al., 2003; Morris and Rui, 2009; Myers et al.,
2009).
This increase of sympathetic outflow can produce profound
effects on various homeostatic functions including the modula-
tion of cardiovascular dynamics such as arterial blood pressure
(Friedman, 2002; Correia and Rahmouni, 2006). Leptin also reg-
ulates blood pressure via augmentation of renal sympathetic
nerve activity (RSNA); events which are believed to play a sig-
nificant role in the development of hypertension (Hall et al.,
2010). This change in RSNA and blood pressure after leptin
administration is absent in experimental animals that have defec-
tive leptin receptors (i.e., Zucker Rats and db/dbmice), suggesting
that these effects are leptin receptor mediated (Haynes et al., 1997;
Rahmouni et al., 2003).
The majority of leptin signaling studies have been conducted
in the hypothalamus, and acute administration of leptin into
regions of the hypothalamus associated with control of cardio-
vascular functions has been shown to increase RSNA and blood
pressure (Marsh et al., 2003; Shih et al., 2003; Rahmouni and
Morgan, 2007). However, the long form of the leptin recep-
tor (ObRb) is located throughout the central nervous system
(Patterson et al., 2011), and there is growing evidence that extra-
hypothalamic leptin signaling plays a critical role in autonomic
regulation (Myers et al., 2009). In fact, the caudal hindbrain,
which contains several populations of preautonomic neurons,
may be a critical site for mediating leptin’s effect on sympa-
thetic outflow (Grill and Kaplan, 2002; Grill, 2010). For exam-
ple, acute injection of leptin into the nucleus of the solitary
tract (NST), located in the dorsal hindbrain, has been shown
to increase RSNA (Mark et al., 2009; Ciriello and Moreau,
2013).
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The rostral ventral lateral medulla (RVLM), located within the
hindbrain, contains neurons which play a key role in determin-
ing peripheral sympathetic vasomotor tone and blood pressure
(Guyenet, 2006). The RVLM integrates multiple descending and
cervical-thoracic (barosensor) inputs regulating sympathetic out-
flow. The RVLM is a “pre-sympathetic” structure in that it sends
axons to the intermediolateral cell column; the source of sympa-
thetic preganglionic neurons. Our laboratory reported that leptin
receptors are expressed by adrenergic/noradrenergic C1/A1 cells
located in the ventrolateral medulla (Barnes et al., 2010), which
overlaps the RVLM. Therefore, the possibility exists that preauto-
nomic blood pressure neurons in the RVLM may express leptin
receptors and that leptin may regulate blood pressure and RSNA
directly by increasing the activity of these neurons. The present
study was conducted to determine if RVLM neurons projecting
through multi-synaptic pathways to the kidney indeed express
leptin receptors and whether acute administration of leptin into
the RVLM influences RSNA as well as cardiovascular dynamics.
MATERIALS AND METHODS
ANIMALS
Male Long Evan rats (8–10 weeks old) obtained from Charles
Rivers were used in these studies. All animals weremaintained in a
roomwith a 12:12 light-dark cycle with constant temperature and
humidity, and given food and water ad libitum. All experimental
protocols were performed according to the guidelines set forth
by the National Institutes of Health and were approved by the
Institutional Animal Care and Use Committees at the Pennington
Biomedical Research Center.
PSEUDO RABIES VIRUS INJECTIONS
Co-localization of ObRb on RVLM neurons with projections to the
kidney
Long Evans rats (n = 5) were anesthetized with a ketamine
(90mg/kg) and xylazine (9mg/kg) cocktail. Using aseptic tech-
nique, a flank incision was made to expose the left kidney.
Animals received two injections (2µl each) of pseudo rabies virus
152 (PRV), green fluorescent trans-neuronal tracer virus, into
the cortex of the kidney using a Hamilton syringe. The injec-
tion site was immediately sealed with liquid bandage (Thermo
Fisher Scientific, Pittsburgh PA). The kidney was returned into
its appropriate position; overlying skin was sutured with Vicryl
and the animal was returned to its home cage for recovery.
Four (4) days after the injection, animals were anesthetized
with urethane (1mg/kg) and transcardially perfused with 0.1M
Phosphate-Buffered Saline (PBS) followed by 4% paraformalde-
hyde. Brains were removed and processed for immunohistochem-
ical demonstration of trans-neuronal tract-tracing and leptin
receptor expression.
IMMUNOHISTOCHEMISTRY
The hindbrain was cut into 30 micron thick sections on a freez-
ing microtome, washed three times with 0.1M PBS, placed in a
blocking solution of 10% goat serum (Jackson ImmunoResearch,
West Grove PA) containing 0.3% Triton X-100 (Sigma Aldrich,
Saint Louis, MO) for 60min and incubated for 72 h at 4◦C in the
primary antibody, chicken anti-ObRb [(1:50) (Neuromics, Edina
MN)]. Sections were then washed three times with 0.1M PBS
followed by 60min incubation in Alexa 594 goat anti-chicken
antibody [(1:100) (Invitrogen, Grand Island NY)] followed by
three rinses with 0.1M PBS prior to being mounted on slides with
ProLong Gold anti-fade reagent (Invitrogen, Grand Island NY).
No additional immunohistochemical processing was necessary to
visualize the green fluorescent protein expression induced by our
PRV injections. Note that heat-induced antigen retrieval method
used in our previous studies of leptin receptor expression in the
hindbrain (Barnes et al., 2010) led to quenching of the green fluo-
rescent signal induced via our renal injections of PRV. Therefore,
comparable ObRb staining was accomplished by both increasing
the concentration of the primary antibody to 1:50 and increasing
the incubation time from 12 to 72 h, as described above.
QUANTIFICATION OF IMMUNOHISTORY
Histological sections containing the majority of the anterior to
posterior extent of the hindbrain [(9–14.5mm post Bregma);
(Paxinos and Watson, 2007)] were examined for evidence of
PRV and ObRb positive cell bodies in the ventral half of the
hindbrain. Sections were visualized with an Axioplan 2 upright
microscope (Carl Zeiss Microscopy, Thornwood, NY) equipped
with a Lambda LS 175W Xenon arc lamp. A FITC filter set (EX
HQ487/25, EM GQ535/40, D Q505lp) was used to visualize the
green PRV staining, while a CY3 filter set (EX HQ535/50, EM
HQ610/75, D Q565lp) was used to visualize the ObRb staining.
Images of positive staining were captured using a CoolSnap HQ
CCD camera (Photometrics, Tucson, AZ). Slidebook Software
(v2.0; Intelligent Imaging Innovations, Denver CO) was used
to generate two dimensional montages of the entire ventral
hindbrain of each section which demonstrated positive stain-
ing using a Plan Apochromat 20×/0.75 NA objective (Carl Zeiss
Microscopy, Thornwood, NY). The numbers of PRV and ObRb
positive cells within hindbrain nuclei, as well as the numbers of
double labeled cells in each image were quantified.
PHYSIOLOGICAL EFFECTS OF LEPTIN INJECTION INTO RVLM
Measurement of renal sympathetic nerve activity and blood
pressure
Male Long Evan rats (n = 6 per group) were anesthetized
with long acting thiobutabarbital (inactin) [(150mg/kg); (Sigma
Aldrich, St. Louis, MO)] which has minimal interference with
autonomic reflexes (Buelke-Sam et al., 1978). Using aseptic tech-
niques, a trachea tube was inserted to allow the airway of the
animal to remain patent. The left femoral artery was catheterized
with PE 20 tubing attached to an AD Instrument transducer for
measurement of blood pressure with a PowerLab data acquisition
system (AD Instruments, Colorado Springs, CO). The animals
were placed in a stereotaxic frame; the occipital plate was removed
to expose the hindbrain. A flank incision was made to expose the
right kidney and the renal nerve. The renal nerve was separated
from the renal vein and renal artery, placed on bipolar platinum-
iridium electrodes (A-M Systems, Carlsborg WA) and secured
with kwik cast gel (World Precision Instruments, Sarasota, FL).
Renal sympathetic nerve activity (RSNA) and mean arterial pres-
sure (MAP) and heart rate (HR) were monitored continuously.
Once preparatory surgery and instrumentation was completed,
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animals were allowed to stabilize for 60min. A triple barrel
glass micropipette (total tip diameter was 150 micron) contain-
ing glutamate [(10mM); (Sigma Aldrich, St. Louis, MO)], saline
(0.9%), leptin [(0.3, 1, or 3µg); (Peprotech, Rocky Hill, NJ)] or
a superactive rat leptin antagonist [(1 ng); (SLAN-4); (Shpilman
et al., 2011; Gertler and Elinav, 2014); (Protein Laboratories
Rehovot)] was lowered into the RVLM at the following coordi-
nates relative to the calamus scriptorius (2.9mm rostral, 1.9mm
lateral, 2.7mm ventral). Confirmation of pipette location was
accomplished with nano-injections of glutamate (40 nL, 10mM),
as described by Goodchild et al. (1982), which elicited rapid
increases in blood pressure. Similar techniques have been used
in previous investigations of the RVLM in regulation of auto-
nomic function (e.g., Adams et al., 2007). After confirmation of
the injection site via glutamate, animals were allowed to recover
for 30min prior to the start of the experiment. Each animal served
as its own control.
Triple barrel pipettes were filled and administered (40 nL)
accordingly: glutamate (10mM)—0.9% saline—leptin (0.3µg);
glutamate—saline—leptin (1µg); glutamate—saline—leptin
(3µg); glutamate—saline—SLAN-4 (1 ng); glutamate—SLAN-
4—leptin (3µg); glutamate—saline—Chicago Blue.
STATISTICS
Physiological experiments
Each animal served as its own control.MAP and RSNAweremon-
itored continuously throughout the experiment; measurement of
these parameters was analyzed at 4min intervals. Time course
response of MAP is shown in Figures 4A, 5A as a percent change
from baseline. Statistical analysis of mean MAPs before and after
the first CNS injection were not significantly different (data not
shown); therefore, “baseline” mean MAP for each animal was
defined as that value at time −15min. Changes in MAP and
RSNA occurring after the second CNS injection were statistically
analyzed across all groups.
Raw RSNA was corrected by subtraction of background noise
as determined at the termination of the experiment. These cor-
rected values were used to determine the percent change of RSNA
from baseline (i.e., mean corrected values obtained 15min fol-
lowing the first injection). Analysis of the peak MAP responses
and RSNA were made using One-Way ANOVA followed by
Bonferroni post-hoc multiple comparison tests. Statistics were
performed using GraphPad Prism Version 5.01 (LaJolla CA).
All values are expressed as mean ± s.e.m. p-value < 0.05 was
considered statistically significant.
RESULTS
HISTOLOGY
ObRb positive cells in the ventral medulla were found in the C1/A1
cell group and the ventromedial region
Cells in the ventral hindbrain that were positive for ObRb stain-
ing (i.e., expressed leptin receptors) were localized in one of four
regions: the C1/A1 cell column, ventromedial medulla (VMM),
caudal raphe, and A5 cell group. The ObRb staining in the C1/A1,
caudal raphe, and A5 was quite distinct and easily assigned to
these medullary nuclei based on Paxinos and Watson (2007)
(Figure 1). In contrast, the staining in the VMM was diffuse
and often overlapped adjacent nuclei such as the paragiganto-
cellular nuclear subdivisions, the reticular nucleus subdivisions,
and the inferior olive (Figure 2A). ObRb positive cells (ObRb+)
were defined as those cells which displayed extensive cytoplasmic
ObRb staining (see insets of Figures 1, 2C), as opposed to cells
whichmerely displayed isolated ObRb punctate staining. An aver-
age of 420 ± 87 ObRb+ cells were observed in C1/A1, 146 ± 32
ObRb+ cells were observed in VMM, 107 ± 87 ObRb+ cells were
observed in A5, and 26 ± 14 ObRb+ cells were observed in the
caudal raphe (Table 1).
Pseudo rabies (PRV) positive neurons identified in the ventral
hindbrain after injection in the cortex of the left kidney
Our PRV kidney injection paradigm labeled cells in C1/A1,
VMM, caudal raphe and A5 (Figure 2). An average of 88 ± 30
PRV+ cells were observed in C1/A1, 113 ± 81 PRV+ cells were
observed in VMM, 35 ± 21 PRV+ cells were observed in A5, and
73 ± 42 PRV+ cells were observed in the caudal raphe (Table 1).
PRV+ cells in C1/A1 were concentrated in the rostral portion
of the cell column, consistent with specific labeling of RVLM
neurons. There were no differences in the number of PRV+ cell
on the contralateral and ipsilateral hemispheres relative to the
site of renal injection. These results confirm a number of previ-
ous studies which employed PRV injection into the renal cortex
(Schramm et al., 1993; Huang and Weiss, 1999; Sly et al., 1999;
Weiss et al., 2001), as well as studies employing PRV injected into
organs which receive substantial sympathetic inputs (Strack et al.,
1989a,b; Sved et al., 2001).
A subset of hindbrain neurons projecting through multi-synaptic
pathways to the kidney expressed ObRb
A subset of PRV labeled neurons within the hindbrain were also
leptin receptor expressing cells (Figure 2). An average of 59 ±
19 double labeled cells were observed in C1/A1, 50 ± 38 dou-
ble labeled cells were observed in VMM, 30 ± 19 double labeled
cells were observed in A5, and 16 ± 12 double labeled cells were
observed in the caudal raphe. Thus, approximately 67% of C1/A1
cells that were PRV+ also expressed leptin receptors compared to
45% in VMM, 22% in caudel raphe and 85% of all PVR+ cells in
A5 (Table 1).
PHYSIOLOGY
RVLM identified by nano-injection of glutamate
RVLM neurons were identified by nano-injection of glutamate
which elicited aminimum increase of 15mmHg in blood pressure
within 15 s (Figure 3) and an increase in RSNA which preceded
the change in blood pressure (Figures 3B,C). The effect of glu-
tamate on blood pressure and RSNA had a short duration; all
parameters returned to baseline within 15min. At the conclusion
of the experiments, a subset of animals was injected with Chicago
Blue to further verify the location of the injection site (Figure 3A).
Microinjection of leptin into the RVLM produced an increase in
mean arterial pressure (MAP) and renal sympathetic nerve activity
(RSNA)
Long Evan rats received one of three doses of leptin into the
RVLM to observe the effect on MAP and RSNA (Figure 4).
Figure 4A displays the percent change in MAP over time in
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FIGURE 1 | Demonstration of leptin receptor (ObRb) positive cells at
various points along the rostrocaudal axis of the ventral hindbrain.
Images in the right column show corresponding histological staining for
ObRb (red labeled cells) in the ventral hindbrain at the level of the A5
cell group (A), RVLM (B), C1 cell group (C), and A1 cell group (D).
Insets on the right column show histological staining of ObRb at higher
magnification in order to show cellular detail. The A5, RVLM, and
C1/A1 cell groups described by Paxinos and Watson (2007) are
represented in the pictographs, reprinted with permission, in the left
column. Scale bars = 200 microns (insets) and 500 microns.
response to saline, 0.3, 1, or 3µg of leptin injected into the RVLM.
Analysis of percent change in MAP was conducted with one-way
ANOVA which compared the MAP at 12min following injection
between each experimental condition (Figure 4B). In response to
leptin (1 and 3µg) MAP increased 8.3 ± 2.9% and 7.6 ± 2.1%
respectively. The MAP response to these treatments was signif-
icantly different from saline (−1.7 ± 1.6%) and leptin (0.3µg)
(−2.4 ± 1.0%) [F(3, 14) = 8.019; p < 0.05]. One-way analysis of
MAP prior to and following the first injection (saline) was not
statistically different (data not shown).
A One-Way ANOVA was also conducted to compare the effect
of each treatment on the percent change of RSNA. There was a sig-
nificant effect [F(3, 24) = 7.493; p < 0.05] of leptin (1 and 3µg)
on the percent change of RSNA when compared to saline and
leptin (0.3µg). Leptin (1 and 3µg) increased RSNA 49 and 34%
respectively, whereas saline changed RSNA 1% and leptin (0.3µg)
caused a 12% increase.
Microinjection of rat superactive leptin antagonist (SLAN-4)
eliminates leptin-induced increases in MAP and RSNA
The role of leptin receptors within the RVLM as it relates to
cardiovascular parameters was assessed using the rat superac-
tive leptin antagonist, SLAN-4. The time course response of
MAP after administering leptin and SLAN-4 into the RVLM is
presented in Figure 5A. A One-Way ANOVA of peak responses
measured at 12min following the second injection demonstrated
a statistically significant effect of treatment [F(3, 16) = 16.64; p <
0.05]. Leptin (3µg) administration resulted in a 7.6 ± 2.1%
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increase in MAP while SLAN-4 alone resulted in a 3.6 ± 0.8%
decrease at the same time point. When SLAN-4 was adminis-
tered into the RVLM prior to leptin (3µg), leptin administration
failed to produce an increase in MAP, and a decrease of 3.2
± 0.6% was observed. 12min following the second injection,
the MAP responses to leptin (3µg) alone was significantly dif-
ferent from the response to saline, SLAN-4, and SLAN-4 plus
leptin (3µg). The MAP response to SLAN-4 alone and SLAN-
4 plus leptin (3µg) were not significantly different from saline
(Bonferroni post-hoc t-tests; p < 0.05) (Figure 5B). A One-Way
ANOVA of percent change in RNSA across treatment was sta-
tistically significant [F(3, 19) = 8.288; p < 0.05]. Following saline
injection, leptin (3µg) administration resulted in a 34% increase
in RNSA while SLAN-4 resulted in a 20% decrease. When SLAN-
4 was administered into the RVLM prior to leptin (3µg), a 13%
decrease in RNSA was observed. The change in RNSA in response
to leptin (3µg), SLAN-4, and SLAN-4 plus leptin (3µg), were all
significantly different from saline control injections (Bonferroni
post-hoc t-tests; p < 0.05) (Figure 5C).
DISCUSSION
Our previous work demonstrated the presence of leptin recep-
tor (ObRb) staining on tyrosine hydroxylase positive neurons in
FIGURE 2 | Dual localization of leptin receptors (ObRb; red) and
pseudo rabies virus infected cells (PRV; green) resulting from renal
PRV injection. (A) Is a low power montage of the complete ventral half of
the medulla at the level of the RVLM. (B–D) Are high magnification of cell
cluster in left RVLM shown in (A) demonstrating PRV positive RVLM
neurons (B), ObRb expressing RVLM neurons (C), and double labeled
RVLM neurons (D). Scale bar = 100 microns.
the medulla which make up the C1/A1 cell group (Barnes et al.,
2010). The current report has built on this observation and fur-
ther quantified the relative distribution of leptin receptor positive
(ObRb+) cells in various nuclei of the ventral medulla. We have
demonstrated that the vast majority of ObRb+ cells are present
in C1/A1 cell column and this staining extends along the com-
plete anterior to posterior extent of this cell group (Figure 1;
Table 1). Several ObRb+ cells were also observed in the caudal
raphe, but the relative number of cells present was minor in com-
parison to C1/A1 cell group. Furthermore, through the use of
PRV, a polysynaptic retrograde tracer, we demonstrated that a
substantial subpopulation of neurons that express leptin recep-
tors (ObRb) projects to the kidney. We determined that a large
percentage of kidney projecting neurons in both the C1/A1 cell
group and the A5 cell group express ObRb, approximately 67 and
85% respectively. We quantified additional neurons that had lep-
tin receptors and projected to the kidney in the VMM and caudal
raphe, approximately 45 and 22% respectively (Table 1).
As stated previously, the labeling pattern resulting from our
renal PRV injections is consistent with a number of previ-
ous studies utilizing the same or similar techniques (Strack
et al., 1989a; Schramm et al., 1993; Huang and Weiss, 1999;
Sly et al., 1999; Weiss et al., 2001). Injections of trans-neuronal
tract tracing into the cortex of the kidney have been consis-
tently shown to retrogradely label hindbrain neurons within the
RVLM, VMM, A5 cell group, and the caudal raphe. However,
our observation that significant subsets of these labeled neurons
are ObRb+ is completely novel. Previous studies investigating the
phenotype of kidney projecting hindbrain neurons have reported
that a subpopulation of these cells express tyrosine hydroxylase
(TH), phenylethanolamine-N-methyltransferase (PNMT) and/or
5-hydroxytryptamine (5-HT), i.e., are catecholaminergic, nora-
drenergic, or serotonergic neurons (Huang and Weiss, 1999).
Additionally, it has been shown that a small subset (<15%) of
neurons in the ventral hindbrain that projects to the kidney
express nitric oxide synthase (nNOS). Further studies will be
needed to identify which of these neuronal subpopulations also
express ObRb.
Microinjection of leptin into the RVLM, the rostral most sub-
division of the C1/A1 which houses neurons associated with
control of vasomotor tone and blood pressure (Pilowsky and
Goodchild, 2002; Guyenet, 2006), caused an increase in both
MAP, approximately 9mmHg, and RSNA, approximately 50%.
Furthermore, when microinjection of leptin (3µg) was preceded
by focal administration of the leptin antagonist, SLAN-4 (1 ng),
this leptin mediated cardiovascular response was eliminated. In
Table 1 | Distribution of leptin receptor (ObRb) expressing and psuedorabies virus (PRV) infected cells in the ventral hindbrain
(mean ± s.e.m., n = 5).
Hindbrain Number of ObRb Number of PRV Number of double % of PRV cells positive
region positive cells infected cells labeled cells for ObRb
A5 107 ± 11 35 ± 21 30 ± 19 85 ± 4
C1/A1 420 ± 87 88 ± 30 59 ± 19 67 ± 2
VMM 146 ± 32 113 ± 81 50 ± 38 45 ± 7
Caudal raphe 26 ± 14 73 ± 42 16 ± 12 22 ± 13
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FIGURE 3 | Histological and physiological verification of RVLM injection
site. A subset of animals received Chicago Blue injection at the end of the
glutamate identification procedure to verify histological placement of pipette.
Coronal sections through the hindbrain were used to identify the injection
site at the level of the RVLM (A). Scale bar = 500 microns. Microinjection of
glutamate (10mM; 40 nL) into the RVLM evoked transient increase in MAP
(B) and renal sympathetic nerve activity (C) within 30 s of injection. These
parameters returned to baseline levels within 15min of the injection.
FIGURE 4 | Nano-injection of leptin into the RVLM increased MAP and
RSNA. Nano-injection of leptin (1 and 3µg; 40 nL) into the RVLM increased
MAP (A). Analysis of percent change in MAP was conducted with One-Way
ANOVA which compared the MAP at 12min following injection between each
experimental condition (B). Peak response of leptin (1 and 3µg) was 8.9 ±
2.9% and 7.6 ± 2.1% respectively. The MAP response to these treatments
was significantly different from saline (−1.6 ± 1.6%) and leptin (0.3µg)
(−2.4 ± 1.0%). Leptin (1 and 3µg) increased RSNA (C) 49 and 34%,
respectively. (Bonferroni t-tests; ∗p < 0.05); arrows indicate time of first
(−15min) and second (0min) injection. Analysis of percent change following
the first inject was not statistically different from values obtained prior to the
first injection.
addition, microinjection of SLAN-4 into the RVLM, with or
without leptin co-administration, caused a significant reduction
in RSNA, approximately 13 and 20% respectively. The response
produced by the highly specific leptin antagonist, SLAN-4, alone
suggests that leptin receptor activation in the RVLM has an
effect on tonic RSNA activity. These data are the first demon-
stration that neurons within the RVLM express functional leptin
receptors and can respond to leptin by increasing RSNA and
mean arterial blood pressure. Taken together, our results suggest
that leptin may regulate renal sympathetic tone and ultimately
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FIGURE 5 | Nano-injection of rat superactive leptin antagonist (SLAN-4)
attenuated the leptin-induced increase in MAP and RSNA and decreased
basal RSNA. Time course response of MAP after administering leptin and
SLAN-4 into the RVLM is presented in (A). 12min following the second
injection, MAP was increased following saline + leptin relative to saline +
saline controls, while saline + SLAN-4 and SLAN-4 + leptin treatment did not
significantly alter MAP relative to saline + saline treatment (B). In contrast,
saline + leptin treatment caused a significant increase in RNSA, while saline
+ SLAN-4 and SLAN-4 + leptin treatment caused a significant decrease in
RNSA relative to saline + saline controls. (C) (Bonferroni t-tests; ∗p < 0.05).
blood pressure by modulating the activity of neurons within
the RVLM.
Leptin’s influence on cardiovascular dynamics is well estab-
lished. Intracerebroventricular (ICV) injection of leptin has been
shown to increase RSNA and/or MAP in a variety of animal
models (Dunbar et al., 1997; Casto et al., 1998; Matsumura
et al., 2000; Rahmouni et al., 2003; Rahmouni and Morgan,
2007; Prior et al., 2010). Furthermore, direct microinjection of
leptin into discrete hypothalamic nuclei (i.e., ventromedial, dor-
somedial, arcuate, and paraventricular nuclei) and the nucleus of
the solitary tract (NTS), leads to increases in MAP and RSNA
(Marsh et al., 2003; Shih et al., 2003; Montanaro et al., 2005;
Rahmouni and Morgan, 2007; Mark et al., 2009; Ciriello and
Moreau, 2012). In the majority of these studies, changes in both
MAP and RSNA were observed with peak changes observed at
approximately 15–25min post injection. These response dynam-
ics were similar to those observed in the present study (see
Figures 4A, 5A). The magnitude of our observed leptin induced
changes in MAP were also similar to the above microinjection
studies which reported changes in MAP from approximately 8
(Marsh et al., 2003) to 17mmHg (Shih et al., 2003; Rahmouni
and Morgan, 2007), with the exception of Ciriello and Moreau
(2012), which reported a maximum increase of approximately
32mmHg following microinjection into the NTS. In contrast,
our leptin mediated increases in RSNA were slightly less than
that reported in other microinjection studies, which ranged from
approximately 65% (Ciriello and Moreau, 2012) to 110% (Mark
et al., 2009). Furthermore, the dose of leptin required for maxi-
mal response in both MAP and RSNA in the current study (1µg)
was similar to that reported by Mark et al. (2009) in the NTS, but
greater than that required by Ciriello and Moreau (2012) in the
NTS (0.1µg) and other studies utilizing microinjection of lep-
tin (0.02–0.5µg) in hypothalamic nuclei (Marsh et al., 2003; Shih
et al., 2003; Rahmouni andMorgan, 2007). These differences may
be caused by the reduced density of ObRb receptors in the RVLM
(see Figure 1) relative to NTS (e.g., Barnes et al., 2010) and the
hypothalamus (e.g., Zhang et al., 2011).
One of the most intriguing finding in the present study is
that pharmacological blockade of leptin receptor signaling in
the RVLM via the newly developed leptin antagonist, SLAN-4,
lead to decreased MAP and RSNA. SLAN-4 is a rat superactive
leptin antagonist with similar properties to the recently devel-
oped mouse superactive leptin antagonist (Shpilman et al., 2011).
These mutated leptin molecules have been shown to have potent
effects on feeding and body weight in vivo (Elinav et al., 2009;
Shpilman et al., 2011; Chapnik et al., 2013). These data provides
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further support to the role of leptin in regulating cardiovascular
parameters. Indeed, administering leptin results in a significant
increase in blood pressure and renal sympathetic activity. Taken
together, our findings suggest that endogenous leptin may act
locally at the level of the RVLM to influence blood pressure in
the normotensive state.
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